129 related articles for article (PubMed ID: 2444899)
1. Behavioural characterization of substance P-induced nociceptive response in mice.
Takahasi K; Sakurada T; Sakurada S; Kuwahara H; Yonezawa A; Ando R; Kisara K
Neuropharmacology; 1987 Sep; 26(9):1289-93. PubMed ID: 2444899
[TBL] [Abstract][Full Text] [Related]
2. Behavioural responses induced by intrathecal injection of 5-hydroxytryptamine in mice are inhibited by a substance P antagonist, D-Pro2, D-Trp7,9-substance P.
Fasmer OB; Post C
Neuropharmacology; 1983 Dec; 22(12A):1397-400. PubMed ID: 6198594
[TBL] [Abstract][Full Text] [Related]
3. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
[TBL] [Abstract][Full Text] [Related]
4. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
[TBL] [Abstract][Full Text] [Related]
5. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
Post C; Folkers K
Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
[TBL] [Abstract][Full Text] [Related]
6. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
7. Is substance P a primary afferent neurotransmitter for nociceptive input? IV. 2-Amino-5-phosphonovalerate (APV) and [D-Pro2,D-Trp7,9]-substance P exert different effects on behaviors induced by intrathecal substance P, strychnine and kainic acid.
Bossut D; Frenk H; Mayer DJ
Brain Res; 1988 Jul; 455(2):247-53. PubMed ID: 2456842
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies on lappaconitine: antinociception and inhibition of the spinal action of substance P and somatostatin.
Ono M; Satoh T
Jpn J Pharmacol; 1991 Apr; 55(4):523-30. PubMed ID: 1715927
[TBL] [Abstract][Full Text] [Related]
9. The behavioural effects of intrathecally administered [D-PRO2, D-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat.
Rodriguez RE; Salt TE; Cahusac PM; Hill RG
Neuropharmacology; 1983 Feb; 22(2):173-6. PubMed ID: 6188071
[TBL] [Abstract][Full Text] [Related]
10. Different role of 5-HT1A and 5-HT2 receptors in spinal cord in the control of nociceptive responsiveness.
Eide PK; Hole K
Neuropharmacology; 1991 Jul; 30(7):727-31. PubMed ID: 1717872
[TBL] [Abstract][Full Text] [Related]
11. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
12. Behavioural assessment as substance P antagonists in mice.
Sakurada T; Kuwahara H; Sakurada S; Kisara K; Ohba M; Munekata E
Neuropeptides; 1987 Apr; 9(3):197-206. PubMed ID: 2439938
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the hyperalgesic effect induced by intrathecal injection of substance P.
Matsumura H; Sakurada T; Hara A; Sakurada S; Kisara K
Neuropharmacology; 1985 May; 24(5):421-6. PubMed ID: 2410805
[TBL] [Abstract][Full Text] [Related]
14. Release of substance P by intrathecal KK-3, a newly synthesized Leu-enkephalin derivative.
Takahashi M; Tokuyama S; Kaneto H
Pharmacol Biochem Behav; 1989 Aug; 33(4):843-6. PubMed ID: 2482510
[TBL] [Abstract][Full Text] [Related]
15. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
[TBL] [Abstract][Full Text] [Related]
16. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
Vaught JL; Scott R
Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
[TBL] [Abstract][Full Text] [Related]
17. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
[TBL] [Abstract][Full Text] [Related]
18. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
Wiesenfeld-Hallin Z; Duranti R
Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
[TBL] [Abstract][Full Text] [Related]
19. Intradermal hypertonic saline-induced behavior as a nociceptive test in mice.
Hwang AS; Wilcox GL
Life Sci; 1986 Jun; 38(26):2389-96. PubMed ID: 2425207
[TBL] [Abstract][Full Text] [Related]
20. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
DeLander GE; Wahl JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
